Studies have identified elevated LCK expression within CD5 expressing B cells (11, 25) and the increase of LCK has been implicated as a biomarker for the progression of CLL patients (11, 26). The gene discussed is LCK; the disease is B-cell chronic lymphocytic leukemia.